Status:
COMPLETED
Blood Nitrate/Nitrite Concentrations Following Acute Ingestion of Resync in Men and Women
Lead Sponsor:
University of Memphis
Collaborating Sponsors:
Resync, LLC
Conditions:
Healthy
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
This study evaluates acute ingestion of the dietary supplement Resync on blood nitrate/nitrite concentrations in a sample of men and women. This will be a crossover trial in which participants take al...
Detailed Description
The product known as Resync contains a blend of nitrate-rich foods including beetroot, red spinach, turmeric, ginger root, and aronia berry extracts. Resync is sold commercially and marketed as an erg...
Eligibility Criteria
Inclusion
- BMI 18 - 29.9 kg/m2
- Non-smoker
- Non-vegan
- Not using nitrate-based dietary supplements
Exclusion
- Diagnosed history of diabetes
- Diagnosed history of cardiovascular disease
- Diagnosed history of neurological disease
- Pregnant females
Key Trial Info
Start Date :
October 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04125940
Start Date
October 14 2019
End Date
December 30 2019
Last Update
April 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for Nutraceutical and Dietary Supplement Research
Memphis, Tennessee, United States, 38152